UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Truist Financial Corp

Truist Financial Corp trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 641,298 shares of the healthcare conglomerate’s stock after selling 86,525 shares during the period. Truist Financial Corp owned approximately 0.07% of UnitedHealth Group worth $337,624,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Spinnaker Trust lifted its holdings in UnitedHealth Group by 3.8% in the fourth quarter. Spinnaker Trust now owns 13,397 shares of the healthcare conglomerate’s stock valued at $7,053,000 after acquiring an additional 495 shares during the period. KFA Private Wealth Group LLC grew its position in UnitedHealth Group by 0.8% during the fourth quarter. KFA Private Wealth Group LLC now owns 2,715 shares of the healthcare conglomerate’s stock valued at $1,429,000 after buying an additional 21 shares during the period. Callan Capital LLC raised its position in shares of UnitedHealth Group by 5.9% in the fourth quarter. Callan Capital LLC now owns 882 shares of the healthcare conglomerate’s stock worth $464,000 after acquiring an additional 49 shares during the period. Bryn Mawr Capital Management LLC grew its position in shares of UnitedHealth Group by 7.2% during the 4th quarter. Bryn Mawr Capital Management LLC now owns 37,606 shares of the healthcare conglomerate’s stock valued at $19,798,000 after acquiring an additional 2,519 shares during the period. Finally, McClarren Financial Advisors Inc. boosted its position in UnitedHealth Group by 73.7% during the fourth quarter. McClarren Financial Advisors Inc. now owns 356 shares of the healthcare conglomerate’s stock worth $188,000 after purchasing an additional 151 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on UNH. Morgan Stanley reduced their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. TD Cowen cut their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Barclays lifted their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Oppenheimer reissued an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Trading Up 0.3 %

Shares of UNH stock traded up $1.49 during trading on Friday, hitting $495.35. 2,608,554 shares of the stock traded hands, compared to its average volume of 4,508,195. The firm’s fifty day moving average price is $485.84 and its 200-day moving average price is $514.21. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The firm has a market capitalization of $455.76 billion, a P/E ratio of 30.28, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the company earned $6.26 EPS. The company’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.